In children with autism, a decrease in the gut-derived metabolite TMAO after an anti-inflammatory diet is strongly linked to better ability to switch between tasks and control impulses, with changes in TMAO accounting for more than half of the variation in this cognitive skill.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether reductions in TMAO consistently correlate with improvements in executive flexibility across multiple studies in children with ASD, controlling for diet type, baseline TMAO, and comorbidities.
A systematic review and meta-analysis of at least five RCTs or longitudinal cohorts measuring pre-post TMAO and executive function (e.g., Wisconsin Card Sorting Test, Trail Making B) in children with ASD, using standardized metrics and adjusting for age, baseline cognition, and dietary adherence.
Whether directly lowering TMAO via dietary intervention causes improved executive flexibility in children with ASD, independent of other biomarker changes.
A double-blind RCT with 80 children with ASD, randomized to either a TMAO-lowering diet (low choline/carnitine, high fiber) or a matched control diet, with pre-post measurement of plasma TMAO and executive function (e.g., CPT-II, Stroop) as primary outcomes, and gut microbiota analysis to confirm TMAO pathway modulation.
Whether baseline TMAO levels predict future changes in executive flexibility in children with ASD over time, independent of dietary intervention.
A prospective cohort study following 150 children with ASD for 2 years, measuring TMAO and executive function quarterly without dietary intervention, adjusting for diet, medication, and sleep, to assess whether TMAO predicts longitudinal cognitive trajectory.
Whether children with ASD and poor executive function have higher baseline TMAO levels than those with typical executive function, matched for age and diet.
A case-control study comparing 40 children with ASD and low executive function (≤1 SD below mean) to 40 matched controls (≥1 SD above mean), measuring fasting plasma TMAO, dietary choline intake, and gut microbiota composition, controlling for age, sex, and medication.
Whether TMAO levels are inversely correlated with executive function scores in children with ASD at a single time point.
A cross-sectional analysis of 200 children with ASD, measuring plasma TMAO and executive function (e.g., BRIEF-2 inhibition subscale) at one visit, adjusting for age, sex, BMI, and dietary intake, to assess bivariate associations.